Neuland Lab Ltd.

NEULANDLAB NSE Healthcare Pharmaceuticals
Nifty 500 Smallcap 50 Smallcap 100 Smallcap 250
₹23,455.00
-1.45%
Delayed · cached 15 min

Fair value analysis

NEULANDLAB
Neuland Lab Ltd.
HealthcarePharmaceuticals
₹23,800.00
Close used for this calculation
₹7,823.16Fair value
Financial DNA Score
Profitability · Returns · Balance Sheet · Efficiency · Growth
48/100
Profitability23/25
Returns8/25
Balance Sheet11/25
Efficiency6/25
Growth12/25
Average
Quality radar
48Prof.23/25Ret.8/25Eff.6/25B.Sht11/25Growth12/25

Consensus fair value

₹7,823.16
Above FV
▼ -67.1% against the close used
Model range ₹3,589.72 – ₹10,128.45
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear₹3,589.72Fair value₹7,823.16Bull₹10,128.45
FairClose
52-week traded range
52W low ₹11,555.0052W high ₹23,995.00

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading above the consensus fair value

Neuland Lab Ltd. closed at ₹23,800.00, 204.2% above the consensus fair value of ₹7,823.16 drawn from 8 valuation models.

Financial DNA score 48/100 — Average. P/E of 60.7x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation
₹5,631.37
-76.3%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=9%, r=10%, tg=3%, n=10yr
Graham Number
₹3,589.72
-84.9%
√(22.5 × EPS × BVPS)
EPS=283.71, BVPS=2018.66 · outside Graham range (P/E 60.7, P/B 11.8) — asset-light, treat as a rough floor
P/E Fair Value
₹10,128.45
-57.4%
EPS × 35.7x (sector P/E)
EPS=283.71, Sector P/E=35.7x
Peter Lynch (PEG)
₹7,092.75
-70.2%
EPS × Growth% (PEG = 1 is fair)
EPS=283.71, g=25%
EV/EBITDA
₹9,296.94
-60.9%
(EBITDA × 18x − Net Debt) ÷ Shares
EBITDA=6.72B
Book Value (P/B)
₹7,670.91
-67.8%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=2018.66, ROE=21.2%, g=6%, r=10%
Reverse DCF
₹23,800.00
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 26.7% | Historical: 25%
Margin of Safety
₹4,837.39
-79.7%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=6449.85, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Educational data only. Not a recommendation to buy, sell or hold any security.